Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Non-Current Debt (2014 - 2015)

Updated

Purple Biotech (PPBT) posted Non-Current Debt of -$130,000 for FY2017, compared with -$18,844 in FY2016.

Analysis

Purple Biotech (PPBT) Non-Current Debt (2014 - 2015) Analysis & Trends

Since FY2013, Purple Biotech has reported Non-Current Debt for 5 years.

  • Annual Non-Current Debt has run from a low of -$622,000 in FY2014 to a high of $108,000 in FY2013 over five years.
  • Business Quant data shows PPBT's Non-Current Debt at -$18,844 in FY2016, -$294,000 in FY2015, -$622,000 in FY2014 and $108,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Purple Biotech 249,214.64 191,214.64 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 430,000.00
Sep 30, 2014 -127,000.00
API Access

Purple Biotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PPBT&period=max&api_key=YOUR_API_KEY